Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Varenicline may reduce negative effect while aiding smoking cessation.

Hays JT.

Evid Based Med. 2014 Feb;19(1):23. doi: 10.1136/eb-2013-101435. Epub 2013 Aug 29. No abstract available.

PMID:
23990527
2.

Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal.

Cinciripini PM, Robinson JD, Karam-Hage M, Minnix JA, Lam C, Versace F, Brown VL, Engelmann JM, Wetter DW.

JAMA Psychiatry. 2013 May;70(5):522-33. doi: 10.1001/jamapsychiatry.2013.678.

3.

Smoking cessation interventions: a primer for physicians: Comment on "Use of varenicline for 4 weeks before quitting smoking".

Simon JA.

Arch Intern Med. 2011 Apr 25;171(8):777-8. doi: 10.1001/archinternmed.2011.137. No abstract available.

PMID:
21518947
4.

Effectiveness of coadministration of varenicline, bupropion, and serotonin reuptake inhibitors in a smoking cessation program in the real-life setting.

Issa JS, Abe TO, Moura S, Santos PC, Pereira AC.

Nicotine Tob Res. 2013 Jun;15(6):1146-50. doi: 10.1093/ntr/nts230. Epub 2012 Nov 5.

PMID:
23128516
5.

Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers.

Linden K, Jormanainen V, Linna M, Sintonen H, Wilson K, Kotomäki T.

Curr Med Res Opin. 2010 Mar;26(3):549-60. doi: 10.1185/03007990903542666.

PMID:
20050814
6.

Changes in health-related quality of life with smoking cessation treatment.

Hays JT, Croghan IT, Baker CL, Cappelleri JC, Bushmakin AG.

Eur J Public Health. 2012 Apr;22(2):224-9. doi: 10.1093/eurpub/ckq137. Epub 2010 Sep 30.

PMID:
20884658
7.

Did the introduction of varenicline in England substitute for or add to the use of other smoking cessation medications?

Kotz D, Fidler JA, West R.

Nicotine Tob Res. 2011 Sep;13(9):793-9. doi: 10.1093/ntr/ntr075. Epub 2011 May 4.

PMID:
21543548
8.

[Medical therapy for smoking cessation].

Zeller A.

Ther Umsch. 2010 Aug;67(8):419-25. doi: 10.1024/0040-5930/a000074. German.

PMID:
20687045
9.

Smoking cessation: an overview of treatment options with a focus on varenicline.

Stack NM.

Pharmacotherapy. 2007 Nov;27(11):1550-7. Review.

PMID:
17963463
10.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
11.

Improving the success of treating tobacco smokers.

Rigotti NA.

JAMA Intern Med. 2015 Feb;175(2):272-3. doi: 10.1001/jamainternmed.2014.6921. No abstract available.

PMID:
25545347
12.

Adherence to varenicline in the COMPASS smoking cessation intervention trial.

Catz SL, Jack LM, McClure JB, Javitz HS, Deprey M, Zbikowski SM, McAfee T, Richards J, Swan GE.

Nicotine Tob Res. 2011 May;13(5):361-8. doi: 10.1093/ntr/ntr003. Epub 2011 Feb 24.

13.

Cardiovascular adverse events associated with smoking-cessation pharmacotherapies.

Sharma A, Thakar S, Lavie CJ, Garg J, Krishnamoorthy P, Sochor O, Arbab-Zadeh A, Lichstein E.

Curr Cardiol Rep. 2015 Jan;17(1):554. doi: 10.1007/s11886-014-0554-8. Review.

PMID:
25410148
14.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
15.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
17.

Breaking away from a narrow prescribing protocol for medicinal nicotine.

Stapleton JA.

Addiction. 2008 Apr;103(4):564-5. doi: 10.1111/j.1360-0443.2008.02170.x. No abstract available.

PMID:
18339102
18.

[Varenicline--a new chance for smokers?].

Goniewicz ML, Koszowski B, Czogała J, Sobczak A.

Przegl Lek. 2007;64(10):899-902. Review. Polish.

PMID:
18409337
19.

[On oral medications, especially varenicline].

Kurioka N.

Nihon Rinsho. 2013 Mar;71(3):487-92. Review. Japanese.

PMID:
23631241
20.

Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.

Hajek P, McRobbie HJ, Myers KE, Stapleton J, Dhanji AR.

Arch Intern Med. 2011 Apr 25;171(8):770-7. doi: 10.1001/archinternmed.2011.138.

PMID:
21518946

Supplemental Content

Support Center